Alnylam Pharmaceuticals
ALNY
#596
Rank
ยฃ31.11 B
Marketcap
ยฃ233.19
Share price
1.33%
Change (1 day)
30.65%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company